Pancreatic Cancer Diagnostic Market to Reach $3.2 billion, Globally, by 2035 at 5.9% CAGR: Allied Market Research

The growth of the pancreatic cancer diagnostic market is driven by increase in incidence of pancreatic cancer, technological advancements in diagnostics, and growing awareness and early detection initiatives.

/EIN News/ -- Wilmington, Delaware, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, "Pancreatic Cancer Diagnostic Market by Product (Instruments, and Consumables), Test Type (Imaging Test, Blood Test, and Biopsy), Cancer Type  (Exocrine, and Endocrine), and End User (Hospitals, Diagnostic Centers, and Others): Global Opportunity Analysis and Industry Forecast, 2024-2035". According to the report, the "pancreatic cancer diagnostic market" was valued at $1.6 billion in 2023, and is estimated to reach $3.2 billion by 2035, growing at a CAGR of 5.9% from 2024 to 2035. 

Request Sample of the Report on Global Pancreatic Cancer Diagnostic Market 2035 - https://www.alliedmarketresearch.com/request-sample/A124008 

Prime determinants of growth 

The growth of the pancreatic cancer diagnostic market is driven by increase in incidence of pancreatic cancer, rise in technological advancements in diagnostics, and growing awareness and early detection initiatives. However, high diagnostic cost is expected to restrain the growth of the pancreatic cancer diagnostic market. On the other hand, high growth potential in emerging countries provides lucrative opportunities for the market growth. 

Report coverage & details  

Report Coverage	Details
Forecast Period	2024–2035
Base Year	2023
Market Size in 2023	$1.6 billion
Market Size in 2035	$3.2 billion
CAGR	5.9%
No. of Pages in Report	385
Segments covered	Product, Test Type, Cancer Type, End User and Region.
Drivers	Increase in incidence of pancreatic cancer              Technological advancements in diagnostics              Growing awareness and early detection initiatives
Opportunity	High growth potential in emerging countries
Restraint	High diagnostic cost

Want to Explore More, Connect to our Analyst - https://www.alliedmarketresearch.com/connect-to-analyst/A124008 

The consumables segment to maintain its leadership status throughout the forecast period 

By product, the consumables segment held the largest market share in 2023, accounting for around three-fourths of the pancreatic cancer diagnostic market. This is attributed to the widespread use of consumables in various diagnostic procedures, including molecular testing, imaging, and biopsy analysis. Consumables such as reagents, kits, and assay products are essential for accurate and reliable testing, driving their high demand. 

The imaging test segment to maintain its leadership status throughout the forecast period 

By test type, the imaging test segment held the largest market share in 2023, accounting for more than two-fifths of the pancreatic cancer diagnostic market owing to its widespread use in detecting and staging pancreatic cancer, as well as monitoring treatment response. Imaging modalities such as computed tomography (CT), magnetic resonance imaging (MRI), and endoscopic ultrasound (EUS) play a crucial role in providing detailed visualization of pancreatic tumors.  

The exocrine segment to maintain its leadership status throughout the forecast period 

By cancer type, the exocrine segment held the largest market share in 2023, accounting for more than four- fifths of the pancreatic cancer diagnostic market and is expected to register the highest CAGR during the forecast period. This is attributed to high prevalence of exocrine pancreatic cancers, particularly pancreatic ductal adenocarcinoma (PDAC), which accounts for the majority of pancreatic cancer cases. Exocrine tumors are often diagnosed at advanced stages, necessitating extensive diagnostic testing, including imaging, biopsy, and molecular analysis. 

The hospitals segment to maintain its leadership status throughout the forecast period 

By end user, the hospitals segment held the largest market share in 2023, accounting for around half of the pancreatic cancer diagnostic market owing to availability of advanced diagnostic equipment, high volume of patient visits, and presence of skilled healthcare professionals. Hospitals serve as primary centers for cancer diagnosis and treatment, offering a comprehensive range of diagnostic modalities, including imaging, biopsy, and molecular testing.  

North America held the largest market share in 2023 

Region-wise, North America held the largest market share in 2023, accounting for more than two-fifths of the pancreatic cancer diagnostic market due to the presence of well-established healthcare infrastructure, advanced diagnostic technologies, and a high level of awareness about pancreatic cancer. North America, particularly the U.S., benefits from significant investments in cancer research, early detection programs, and access to cutting-edge diagnostic tools. 

However, the Asia-Pacific is expected to witness the fastest CAGR of 6.6% from 2024 to 2035 owing to the increase in healthcare investments, improving healthcare infrastructure, and rise in awareness about early cancer detection. In addition, the growing incidence of pancreatic cancer, particularly in rapidly developing countries like China and India, is driving the demand for advanced diagnostic technologies. 

For Purchase Related Queries/Inquiry - https://www.alliedmarketresearch.com/purchase-enquiry/A124008 

Leading Market Players 

• Thermo Fisher Scientific Inc. 

• Qiagen N.V. 

• F. Hoffmann-La Roche Ltd. 

• Myriad Genetics, Inc. 

• Fujifilm Holdings Corporation 

• Randox Laboratories Ltd. 

• Clearnote Health 

• Siemens 

• Prestige Biopharma Ltd. 

• Toray Industries, Inc. 

The report provides a detailed analysis of these key players in the pancreatic cancer diagnostic market. These players have adopted strategies such as product approval, agreement, collaboration, and others to increase their market share and maintain dominant shares in different regions. The report is valuable in highlighting business performance, operating segments, product portfolio, and strategic moves of market players to highlight the competitive scenario. 

Trending Reports in Healthcare Industry:  

Structural Heart Devices Market - Global Opportunity Analysis and Industry Forecast, 2024-2035 

Neuroprosthetics Market - Global Opportunity Analysis and Industry Forecast, 2024-2035 

Mechanical Ventilators Market - Global Opportunity Analysis and Industry Forecast, 2024-2035 

Pediatric Ultrasound Market - Global Opportunity Analysis and Industry Forecast, 2024-2035 

AVENUE- A Subscription-Based Library (Premium on-demand, subscription-based pricing model) Offered by Allied Market Research: 

AMR introduces its online premium subscription-based library Avenue, designed specifically to offer cost-effective, one-stop solution for enterprises, investors, and universities. With Avenue, subscribers can avail an entire repository of reports on more than 2,000 niche industries and more than 12,000 company profiles. Moreover, users can get an online access to quantitative and qualitative data in PDF and Excel formats along with analyst support, customization, and updated versions of reports. 

Get an access to the library of reports at any time from any device and anywhere. For more details, follow the link: https://www.alliedmarketresearch.com/library-access 

About Allied Market Research: 

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Wilmington, Delaware. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI. 

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.  

Contact 

David Correa 

1209 Orange Street, 

Corporation Trust Center, 

Wilmington, New Castle, 

Delaware 19801 USA. 

Toll Free: +1-800-792-5285 

Int’l: +1-503-894-6022 

UK: +44-845-528-1300 

Hong Kong: +852-301-84916 

India (Pune): +91-20-66346060 

Fax: +1-855-550-5975 

help@alliedmarketresearch.com   

Web: https://www.alliedmarketresearch.com    

Follow Us on: LinkedIn Twitter